休克病因与VA-ECMO后5年结局的关联
该回顾性观察研究纳入2015年1月至2018年8月在Pitié-Salpêtrière医院接受外周VA-ECMO的连续成人患者,适应证为心源性休克,按病因分析住院死亡及神经、肾脏、肺部并发症。共1253例,住院生存率从原发性移植物衰竭的73.3%到难治性血管麻痹性休克的11.1%不等,5年生存率亦因病因差异显著。结论认为结局差异更多与病因相关病情严重程度有关,而非休克病因本身,5年生存率差异提示需长期随访。
要点
- VA-ECMO支持的心源性休克患者住院生存率因病因不同差异显著,范围11.1%至73.3%。
- 5年生存率亦因病因异质,从0.0%到57.3%不等,提示需长期随访。
- 需血液透析的肾衰竭发生率为50.0%,神经系统并发症16.0%,静水压性肺水肿9.0%。
核心结论
- VA-ECMO后结局虽因病因不同而异,但差异更多与病因相关病情严重程度有关,而非休克病因本身。
- 5年生存率因病因不同,可能反映慢性病自然病程,提示需要长期随访。
研究设计与样本
- 回顾性观察研究,纳入2015年1月至2018年8月Pitié-Salpêtrière医院所有连续接受外周VA-ECMO的成人患者,适应证为心源性休克,共1253例。
主要发现
- 住院和5年生存率分别为:原发性移植物衰竭73.3%和57.3%,药物过量58.6%和54.0%,扩张型心肌病53.2%和45.3%,心律失常风暴51.6%和50.0%,大面积肺栓塞46.8%和38.3%,脓毒症诱导的心源性休克44.4%和42.4%,暴发性心肌炎37.9%和32.9%,急性心肌梗死37.3%和31.5%,排除原发性移植物衰竭的心脏术后34.6%和33.3%,其他/未知病因25.7%和22.8%,难治性血管麻痹性休克11.1%和0.0%。
- 需血液透析的肾衰竭发生率为50.0%,神经系统并发症为16.0%,静水压性肺水肿为9.0%。
临床怎么用
- 临床中应依据VA-ECMO支持患者的休克病因评估预后,并关注长期随访。
局限性
- 本研究为单中心回顾性观察研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Outcomes of patients requiring venoarterial extracorporeal membrane oxygenation (VA-ECMO) vary greatly by etiology, but large studies that incorporate the spectrum of shock supported with ECMO are rare. OBJECTIVES: The purpose of this study was to describe the etiology-related outcome of patients with shock supported with peripheral VA-ECMO. METHODS: All consecutive adults with peripheral VA-ECMO between January 2015 and August 2018 at Pitié-Salpêtrière Hospital (Paris, France) were included in this retrospective observational study. The indication for VA-ECMO was cardiogenic shock. Rates of hospital death and neurological, renal, and pulmonary complications were evaluated according to etiology. RESULTS: Among 1,253 patients, hospital and 5-year survival rates were, respectively, 73.3% and 57.3% for primary graft failure, 58.6% and 54.0% for drug overdose, 53.2% and 45.3% for dilated cardiomyopathy, 51.6% and 50.0% for arrhythmic storm, 46.8% and 38.3% for massive pulmonary embolism, 44.4% and 42.4% for sepsis-induced cardiogenic shock, 37.9% and 32.9% for fulminant myocarditis, 37.3% and 31.5% for acute myocardial infarction, 34.6% and 33.3% for postcardiotomy excluding primary graft failure, 25.7% and 22.8% for other/unknown etiology, and 11.1% and 0.0% for refractory vasoplegia shock. Renal failure requiring hemodialysis developed in 50.0%, neurological complications in 16.0%, and hydrostatic pulmonary edema in 9.0%. CONCLUSIONS: Although the outcome differs depending on etiology, this difference is related more to the severity of the situation associated with the cause rather than the cause of the shock per se. Survival to 5 years varied by cause, which may reflect the natural course of the chronic disease and illustrates the need for long-term follow-up.
引用
- Danial, Olivier, Bréchot, et al. Association Between Shock Etiology and 5-Year Outcomes After Venoarterial Extracorporeal Membrane Oxygenation. J Am Coll Cardiol. 2023. PMID: 36858709. doi:10.1016/j.jacc.2022.12.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。